GH1 and melanoma: Moreover, hGH action is known to drive drug resistance in human melanoma cells by upregulating the expression of multidrug efflux pumps—ABC transporters which allows lower chemotherapeutic retention in the tumor cells, thus enabling chemoresistance (48).